Baxion
Screening
Tags
Alerts
Theme
Minerva Neurosciences, Inc.
NERV
·
NASDAQ
·
$5.22
Share Price as of 11/2
·
$37M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/07/26
10-Q
Q1 ended 03/31/26
05/05/26
10-K
FY 2025
03/11/26
10-Q
Q3 ended 09/30/25
11/05/25
10-Q
Q2 ended 06/30/25
08/14/25
Disclosures
Filter
8-K
Current report
08/12/26
8-K
Current report
08/07/26
8-K
Current report
06/04/26
8-K
Current report
05/27/26
8-K
Current report
05/05/26
Prospectuses and Registrations
Filter
424B5
Prospectus supplement
05/27/26
S-3
Shelf registration
03/11/26
424B3
Prospectus
01/06/26
S-3
Shelf registration
12/23/25
S-8
Registration of securities for employees
12/23/25
Proxies
Filter
DEF 14A
Definitive proxy
04/23/26
DEFA14A
Additional proxy materials
04/23/26
PRE 14A
Preliminary proxy
04/10/26
DEF 14A
Definitive proxy
11/24/25
PRE 14A
Preliminary proxy
11/14/25
Ownership
Filter
Form 3
Initial insider ownership
08/20/26
Form 3
Initial insider ownership
08/20/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
SC 13G/A
Beneficial ownership (amended)
08/13/26
Form 4
Insider transaction
08/03/26
Other
Filter
ARS
Annual report to shareholders
04/23/26
EFFECT
Request for effectiveness
03/19/26
CORRESP
Correspondence with the SEC
03/17/26
UPLOAD
Letter from the SEC
03/16/26
EFFECT
Request for effectiveness
01/06/26
Latest Filings
Filter
8-K
Current report
08/12/26
10-Q
Q2 ended 06/30/26
08/07/26
8-K
Current report
08/07/26
8-K
Current report
06/04/26
8-K
Current report
05/27/26
Ownership
Filter
Form 3
Initial insider ownership
08/20/26
Form 3
Initial insider ownership
08/20/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
SC 13G/A
Beneficial ownership (amended)
08/13/26
Form 4
Insider transaction
08/03/26